Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
In clinical trials, a surrogate endpoint (also called a surrogate measure or surrogate marker) is a measure of effect of a specific treatment that may correlate with a real clinical endpoint but does not necessarily have a guaranteed relationship. The National Institutes of Health (USA) defines surrogate endpoint as "a biomarker intended to substitute…
Examples, Reporting Guidelines & Overview
Explore the main themes, entities and connections around Surrogate endpoint. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
surrogate endpoint clinical used endpoints trials markers correlate disease cholesterol drug approval show trial meaningful fda called marker treatment may
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Overall Treatment Utility.Infectious diseaseIn HIV/AIDS medicine | instance of | More patient focused surrogate endpoints may offer a more meaningful alternative | 0.80 | text |
| CD4 counts | instance of | More patient focused surrogate endpoints may offer a more meaningful alternative | 0.80 | text |
| viral loads are used as surrogate markers for drug approval for clinical trials.In hepatitis C medicine | instance of | More patient focused surrogate endpoints may offer a more meaningful alternative | 0.80 | text |
| the surrogate endpoint | instance of | More patient focused surrogate endpoints may offer a more meaningful alternative | 0.80 | text |
| Overall Treatment Utility | instance of | More patient focused surrogate endpoints may offer a more meaningful alternative | 0.80 | text |
| Surrogate endpoint | related to Cancer | Progression Free Survival | 0.60 | section |
| Surrogate endpoint | related to Cancer | Oncology | 0.60 | section |
| Surrogate endpoint | related to Cancer | There | 0.60 | section |
| Surrogate endpoint | related to Cancer | In | 0.60 | section |
| Surrogate endpoint | related to Cancer | Bevacizumab | 0.60 | section |
| Surrogate endpoint | related to Cancer | Avastin | 0.60 | section |
| Surrogate endpoint | related to Cancer | Food | 0.60 | section |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.